FSLR
47
-2
CHD
21
5
PPL
49
2
IFF
45
-2
HBAN
54
3
HCP
52
7
XEL
50
-3
F
39
3
WMT
66
2
IBM
48
4
CAH
44
7
ADBE
44
-2
JPM
57
5
A
48
4
QRVO
25
17
EL
24
-3
FTI
76
16
SWK
48
2
DAL
50
3
WMB
62
2
FSLR
47
-2
CHD
21
5
PPL
49
2
IFF
45
-2
HBAN
54
3
HCP
52
7
XEL
50
-3
F
39
3
WMT
66
2
IBM
48
4
CAH
44
7
ADBE
44
-2
JPM
57
5
A
48
4
QRVO
25
17
EL
24
-3
FTI
76
16
SWK
48
2
DAL
50
3
WMB
62
2
Financhill
Back

EQB Vs. NovoCure Industry Stock Comparison

Sell
25

EQGPF
EQB

Last Price:
$68.00
Seasonality Move:
-3.03%
Sell
49

NVCR
NovoCure

Last Price:
$30.18
Seasonality Move:
-3.69%
Sell
25
EQB (EQGPF) is a Sell

Is EQB a Buy, Sell or Hold?

  • The current EQB [EQGPF] share price is $68.00. The Score for EQGPF is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • EQGPF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
NovoCure (NVCR) is a Sell

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $30.19. The Score for NVCR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EQGPF Stock Price Chart

What is EQB's stock price today?

  • The EQB share price today is $68.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EQGPF is experiencing slight buying pressure.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $30.19
    The current trend is moderately bullish and NVCR is experiencing slight selling pressure.

EQGPF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.86 Sell
Relative Strength Index (14 RSI): 14.02 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (68.4 - 75) Sell
Bollinger Bands (100): (70.79 - 77.39) Sell

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.94 Buy
Relative Strength Index (14 RSI): 58.79 Buy
Chaikin Money Flow: -60501 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.36 - 32.64) Buy
Bollinger Bands (100): (14.38 - 25.86) Buy

EQGPF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 68.71 Sell
20-day SMA: 70.25 Sell
50-day SMA: 74.35 Sell
200-day SMA: 69.38 Sell
8-day EMA: 68.79 Sell
20-day EMA: 70.47 Sell
50-day EMA: 72.76 Sell
200-day EMA: 69.92 Sell

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.52 Sell
20-day SMA: 30.41 Sell
50-day SMA: 23.25 Buy
200-day SMA: 18.89 Buy
8-day EMA: 30.36 Sell
20-day EMA: 29.22 Buy
50-day EMA: 25.18 Buy
200-day EMA: 21.21 Buy

EQB Earnings Growth & EQGPF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.06 per share.

EQB Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):